Changeflow GovPing Government & Legislation Variance Approval to Blue Martini Naples
Priority review Rule Added Final

Variance Approval to Blue Martini Naples

Favicon for www.regulations.gov Regulations.gov Final Notices
Detected
Email

Summary

FDA's Center for Devices and Radiological Health (CDRH) issued a variance approval letter to Blue Martini Naples, granting an exception to applicable medical device regulations for their Naples, Florida facility. The variance approval allows the establishment to operate under modified regulatory requirements that would otherwise apply under standard FDA medical device quality system regulations. Affected parties must comply with any conditions specified in the approved variance.

Published by FDA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

FDA CDRH issued a variance approval letter to Blue Martini Naples, granting specific regulatory relief from standard medical device requirements applicable to their Naples facility. The variance approval creates modified compliance obligations that supersede standard requirements for the scope specified in the approval.

Facilities holding FDA variances should review approval conditions to ensure continued compliance with any stated requirements or limitations. Regulated entities operating similar facilities should monitor FDA guidance on variance requests if seeking comparable relief.

Archived snapshot

Apr 18, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 1

Variance Approval Letter to Blue Martini Naples

More Information
- Author(s) CDRH
Download

Get daily alerts for Regulations.gov Final Notices

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
FDA-2026-V-2879-0003
Docket
FDA-2026-V-2879-0003

Who this affects

Applies to
Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device manufacturing Regulatory variance requests
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Regulatory Affairs
Compliance frameworks
GxP
Topics
Healthcare Administrative Law

Get alerts for this source

We'll email you when Regulations.gov Final Notices publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!